NURIX THERAPEUTICS INC shareholders Q3 2023

NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 129 filers reported holding NURIX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.

NURIX THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ALLIANCEBERNSTEIN L.P. 46,460$365,1760.00%
UBS Group AG 172,002$1,351,9360.00%
Lindbrook Capital, LLC 333$2,6170.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 5,482$43,0890.00%
Point72 Middle East FZE 651$5,1170.00%
Point72 Asset Management, L.P. 1,114$8,7560.00%
VOYA INVESTMENT MANAGEMENT LLC 32,970$259,1440.00%
JANE STREET GROUP, LLC 11,978$94,1470.00%
Bank of New York Mellon Corp 170,286$1,338,4480.00%
Allspring Global Investments Holdings, LLC 1,235$9,7070.00%
Citadel Advisors 6,300$49,5180.00%
Citadel Advisors 11,200$88,0320.00%
Citadel Advisors 68,468$538,1590.00%
NOMURA ASSET MANAGEMENT CO LTD 0$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 57,722$453,6950.00%
GREAT WEST LIFE ASSURANCE CO /CAN/ 1,891$150.00%
Tower Research Capital LLC (TRC) 888$6,9800.00%
SIGNATUREFD, LLC 906$7,1210.00%
AMERICAN CENTURY COMPANIES INC 30,839$242,3950.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
External links

This page lists NURIX THERAPEUTICS INC's shareholders in Q3 2023. To view NURIX THERAPEUTICS INC's shareholder history, click here.